Behind the scenes of EQA–characteristics, capabilities, benefits and assets of external quality assessment (EQA): Part IV – Benefits for participant laboratories.
10.1515/cclm-2024-1292 · doi-reference
MELD 3.0: The Model for End-Stage Liver Disease Updated for the Modern Era.
10.1053/j.gastro.2021.08.050 · doi-reference
Simplified method for international normalized ratio (INR) derivation based on the prothrombin time/INR line: an international study.
10.1373/clinchem.2009.141937 · doi-reference
Harmonizing the International Normalized Ratio (INR): standardization of methods and use of novel strategies to reduce interlaboratory variation and bias.
10.1093/ajcp/aqv022 · doi-reference
Comparison of local International Sensitivity Index calibration and ‘Direct INR’ methods in correction of locally reported International Normalized Ratios: an international study.
10.1111/j.1538-7836.2007.02452.x · doi-reference
Coagulation parameters reference interval for adult population of Debre Berhan town, Northeast Ethiopia.
10.1186/s12959-025-00808-7 · doi-reference
Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study.
10.1182/blood.2020008698 · doi-reference
Replacement of traditional prothrombin time monitoring with the new Fiix prothrombin time increases the efficacy of warfarin without increasing bleeding. A review article.
10.1186/s12959-021-00327-1 · doi-reference
During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
10.1111/jth.13549 · doi-reference
Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
10.1080/00365513.2018.1474492 · doi-reference
Efficacy of Point-of-Care for INR Testing Compared to Standard Laboratory Methods at a Tertiary Care Hospital in Saudi Arabia.
10.36401/jqsh-19-36 · doi-reference
A Comprehensive Clinical Assessment of the LumiraDx International Normalized Ratio (INR) Assay for Point-of-Care Monitoring in Anticoagulation Therapy.
10.3390/diagnostics14232683 · doi-reference
ICSH guidance for INR and D-dimer testing using point of care testing in primary care.
10.1111/ijlh.14051 · doi-reference
Benefits and Pitfalls of Point-of-Care Coagulation Testing for Anticoagulation Management: An ACLPS Critical Review.
10.1093/ajcp/aqy087 · doi-reference
Regulatory Approved Point-of-Care Diagnostics (FDA & Health Canada): A Comprehensive Framework for Analytical Validity, Clinical Validity, and Clinical Utility in Medical Devices.
10.1093/jalm/jfaf106 · doi-reference
Regulating the future of laboratory medicine: European regulatory landscape of AI-driven medical device software in laboratory medicine.
10.1515/cclm-2025-0482 · doi-reference
Decoding Clot Waveform Analysis: Toward Better Understanding and Harmonization.
10.1055/a-2778-9810 · doi-reference
Implementation of AI systems in the clinical laboratory: insights from an expert survey and recommendations for best practice.
10.1515/cclm-2025-1322 · doi-reference
Machine Learning for Patient-Based Real-Time Quality Control (PBRTQC), Analytical and Preanalytical Error Detection in Clinical Laboratory.
10.3390/diagnostics14161808 · doi-reference
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.
10.1093/europace/euab065 · doi-reference
2021 update of the International Council for Standardization in Haematology recommendations for laboratory measurement of direct oral anticoagulants.
10.1055/a-1450-8178 · doi-reference
Novel Ex Vivo DOAC Removal Methods Reduce Interference in Lupus Anticoagulant Testing.
10.3390/diagnostics12102520 · doi-reference
DOAC-stop can remove direct oral anticoagulants and allow analysis by global coagulation assays.
10.1111/ijlh.14020 · doi-reference
DOACs: role of anti-Xa and drug level monitoring.
10.1182/hematology.2024000666 · doi-reference
Innovative Diagnostic Solutions in Hemostasis.
10.3390/diagnostics14222521 · doi-reference
The influence of the reference mean prothrombin time on the international normalized ratio.
10.1093/ajcp/102.6.806 · doi-reference
Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation.
10.1055/s-0037-1616068 · doi-reference
Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests.
10.1002/hep.20569 · doi-reference
Calibrated automated thrombin generation measurement in clotting plasma.
10.1159/000071636 · doi-reference
Low-molecular-weight heparin in patients with advanced cirrhosis.
10.1111/j.1478-3231.2010.02358.x · doi-reference
The international normalized ratio calibrated for cirrhosis (INR(liver)) normalizes prothrombin time results for model for end-stage liver disease calculation.
10.1002/hep.21732 · doi-reference
Clinical usefulness of international normalized ratio calibration of prothrombin time in patients with chronic liver disease.
10.1007/s12185-015-1820-2 · doi-reference
Standardization of the INR: how good is your laboratory’s INR and can it be improved?
10.1055/s-0028-1104538 · doi-reference
